Ashkan Lashkari is an expert in the field of Oncology. She studied medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is a top medical university. David Geffen School of Medicine at UCLA is ranked 13/7 in Research/PrimaryCare. Ashkan Lashkari has written publications. She has 6 publications published with PubMed. The lastest publication is: 'Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial.' Ashkan Lashkari, MD accepts Medicare payments and is listed with Medicare.gov.
City of Hope National Medical Center
UCLA Medical Center
David Geffen School of Medicine at UCLA
LAC-Olive View-UCLA Medical Center
Ronald Reagan UCLA Medical Center| NPI NUMBER | 1528284627 | |
| NPPES Provider LastName | LASHKARI | |
| NPPES Provider FirstName | ASHKAN | |
| NPPES Provider ZIPCode | 913071474 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1166.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 57.0 | |
| Percent Opioid Claims | 4.89 |
| National Provider Identifier [NPI] | 1528284627 |
| Last Name Of The Provider | LASHKARI |
| First Name Of The Provider | ASHKAN |
| View All |